“…Nationwide alerts were issued to frontline clinicians on 2 December 2022, including a request for identification of routine surveillance reports relating to lower respiratory tract iGAS presentation in children younger than 15 years. Similar concerns about increases in paediatric iGAS cases are also being reported in the Netherlands, France, Ireland and the United States [10][11][12][13][14]. In the Netherlands, the increase seen earlier in 2022 was particularly apparent in children younger than 5 years, with emm types similar to the ones in England for all ages (emm 1, 12 and 4); high levels of chickenpox activity, also noted in England [1,2], were attributed to the rise in iGAS cases [10].…”